> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Thermo Fischer Antimicrobial Susceptibility Plate
- URL: https://www.fdaweb.com/fda-clears-thermo-fischer-antimicrobial-susceptibility-plate/
- Published: 2017-06-29T12:00:00.000Z
- Updated: 2026-09-14T22:32:30.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5139066

FDA has cleared a Thermo Fisher Scientific 510(k) for its microbroth dilution plate for antimicrobial susceptibility of Gram negative organisms, including two of the latest novel compounds — ceftolozane/tazobactam and ceftazidime/avibactam. The plate enables microbiology laboratories to measure true minimum inhibitory concentration (MIC) values of 24 antimicrobials, which are critical in reducing antimicrobial resistance, according to the company. “True MIC values are also the best measure of antibacterial effect, which can assist with therapeutic choices and promote overall better patient care,” it says.

  
Thermo Fisher says the Sensititre Gram Negative GN6F Plate can be read using a range of options, from manual methods to full automation. It also includes a range of standard plates, as well as the ability to create custom plates tailored to a lab’s formulary, dilution ranges and patient population, eliminating offline tests and reducing costs.